The findings in the cohort of CRC patients studied indicate that the tumor content of IF1 is an independent predictor of survival, advancing that a high tumor content of IF1 predicts longer time-periods for disease recurrence. The gene discussed is ATP5IF1; the disease is colorectal carcinoma.